In our study, we characterized CD4+ and CD8+ T cells for their expression of receptors recognizing MIF in order to define the role of this soluble mediator in COVID-19 immunopathology and determine the interplay between these two pathogenic mechanisms. This evidence concerns the gene CD8A and COVID-19.